centigray.com - August 2004

Case Presentations

Adenocarcinoma of the right lung and the impact of high-dose IGRT

August 2004

PDF

Print

E-mail

Azria D, Gourgou S, Sozzi WJ, Zouhair A, Mirimanoff RO, Kramar A, Lemanski C, Dubois JB, Romieu G, Pelegrin A, Ozsahin M.
Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. Br J Cancer. 2004 Aug 24

Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF.
Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004 Aug 19;351(8):781-91.

D'Amico AV, Manola J, Loffredo M, Renshaw AA, DellaCroce A, Kantoff PW.
6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA. 2004 Aug 18;292(7):821-7.

Shen J, Valero V, Buchholz TA, Eva Singletary S, Ames FC, Ross MI, Cristofanilli M, Babiera GV, Meric-Bernstam F, Feig B, Hunt KK, Kuerer HM.
Effective Local Control and Long-Term Survival in Patients with T4 Locally Advanced Breast Cancer Treated with Breast Conservation Therapy. Ann Surg Oncol. 2004 Aug 16

Sarosdy MF.
Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy. Cancer. 2004 Aug 15;101(4):754-60.

Flam TA, Peyromaure M, Chauveinc L, Thiounn N, Firmin F, Cosset JM, Bernard D.
Post-brachytherapy transurethral resection of the prostate in patients with localized prostate cancer. J Urol. 2004 Jul;172(1):108-11.

Sadahiro S, Suzuki T, Ishikawa K, Fukasawa M, Saguchi T, Yasuda S, Makuuchi H, Murayama C, Ohizumi Y.
Preoperative radio/chemo-radiotherapy in combination with intraoperative radiotherapy for T3-4Nx rectal cancer. Eur J Surg Oncol. 2004 Sep;30(7):750-8.

Warszawski A, Baumann R, Karstens JH.
Sonographic guidance for electron boost planning after breast-conserving surgery. J Clin Ultrasound. 2004 Sep;32(7):333-7.

Almeida OP, Waterreus A, Spry N, Flicker L, Martins RN.
One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology. 2004 Sep;29(8):1071-81.

Roychoudhuri R, Evans H, Robinson D, Moller H.
Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer. 2004 Aug 3

Johnstone PA, Williams SR, Riffenburgh RH.
The 100-day PSA: usefulness as surrogate end point for biochemical disease-free survival after definitive radiotherapy of prostate cancer. Prostate Cancer Prostatic Dis. 2004 Aug 3

Halyard MY, McCombs KE, Wong WW, Buchel EW, Pockaj BA, Vora SA, Gray RJ, Schild SE.
Acute and chronic results of adjuvant radiotherapy after mastectomy and Transverse Rectus Abdominis Myocutaneous (TRAM) flap reconstruction for breast cancer. Am J Clin Oncol. 2004 Aug;27(4):389-94.

Hill A, Hanson M, Bogle MA, Duvic M.
Severe radiation dermatitis is related to Staphylococcus aureus. Am J Clin Oncol. 2004 Aug;27(4):361-3.

Richards GM, Berson AM, Rescigno J, Sanghavi S, Siegel B, Axelrod D, Bernik S, Scarpinato V, Mills C.
Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol. 2004 Aug;11(8):739-46.

Gomez P, Manoharan M, Kim SS, Soloway MS.
Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? BJU Int. 2004 Aug;94(3):299-302.

Karakiewicz PI, Tanguay S, Kattan MW, Elhilali MM, Aprikian AG.
Erectile and urinary dysfunction after radical prostatectomy for prostate cancer in Quebec: a population-based study of 2415 men. Eur Urol. 2004 Aug;46(2):188-94.

Winter WE 3rd, Maxwel GL, Tian C, Sobel E, Scott Rose G, Thomas G, Carlson JW.
Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study. Gynecol Oncol. 2004 Aug;94(2):495-501.

Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM Jr, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R.
Parathyroid carcinoma: A 22-year experience. Head Neck. 2004 Aug;26(8):716-26.

Makeieff M, Mercante G, Jouzdani E, Garrel R, Crampette L, Guerrier B.
Supraglottic hemipharyngolaryngectomy for the treatment of T1 and T2 carcinomas of laryngeal margin and piriform sinus. Head Neck. 2004 Aug;26(8):701-5.

Zhen W, Karnell LH, Hoffman HT, Funk GF, Buatti JM, Menck HR.
The national cancer data base report on squamous cell carcinoma of the base of tongue. Head Neck. 2004 Aug;26(8):660-74.

Citron JR, Sutton H, Yamada SD, Mehta N, Mundt AJ.
Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1432-8.

McElveen TL, Waterman FM, Kim H, Dicker AP.
Factors predicting for urinary incontinence after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1395-404.

Stock RG, Cahlon O, Cesaretti JA, Kollmeier MA, Stone NN.
Combined modality treatment in the management of high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1352-9.

Langendijk JA, Poorter R, Leemans CR, de Bree R, Doornaert P, Slotman BJ.
Radiotherapy of squamous cell carcinoma of the nasal vestibule. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1319-25.

Namiki S, Tochigi T, Kuwahara M, Ioritani N, Terai A, Numata I, Satoh M, Saito S, Koinuma N, Arai Y.
Health related quality of life in Japanese men after radical prostatectomy or radiation therapy for localized prostate cancer. Int J Urol. 2004 Aug;11(8):619-627.

Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL.
Cisplatin, Fluorouracil, and leucovorin induction chemotherapy followed by concurrent Cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol. 2004 Aug 1;22(15):3061-9.

Freedland SJ, Terris MK, Presti JC Jr, Amling CL, Kane CJ, Trock B, Aronson WJ; Search Database Study Group.
Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. J Urol. 2004 Aug;172(2):520-4.

Hassen-Khodja R, Kieffer E.
Radiotherapy-induced supra-aortic trunk disease: Early and long-term results of surgical and endovascular reconstruction. J Vasc Surg. 2004 Aug;40(2):254-61.

Slomovitz BM, Sun CC, Ramirez PT, Bodurka DC, Diaz P, Lu KH.
Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer? Obstet Gynecol. 2004 Aug;104(2):255-60.

Baumert BG, Villa S, Studer G, Mirimanoff RO, Davis JB, Landau K, Ducrey N, Arruga J, Lambin P, Pica A.
Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma. Radiother Oncol. 2004 Aug;72(2):169-74.

Bussels B, Maes A, Hermans R, Nuyts S, Weltens C, Van Den Bogaert W.
Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol. 2004 Aug;72(2):119-27.

Schneider O, Stuckle CA, Bosch E, Gott C, Adamietz IA.
Effectiveness and prognostic factors of radiotherapy for painful plantar heel spurs. Strahlenther Onkol. 2004 Aug;180(8):502-9.

D'Amico AV, Chen MH, Roehl KA, Catalona WJ.
Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med. 2004 Jul 8;351(2):125-35.

Ramos CG, Roehl KA, Antenor JA, Humphrey PA, Catalona WJ.
Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. J Urol. 2004 Jul;172(1):137-40.

Lee JL, Park SI, Kim SB, Jung HY, Lee GH, Kim JH, Song HY, Cho KJ, Kim WK, Lee JS, Kim SH, Min YI.
A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol. 2004 Jun;15(6):947-54.

Peschel RE, Colberg JW, Chen Z, Nath R, Wilson LD.
Iodine 125 versus palladium 103 implants for prostate cancer: clinical outcomes and complications. Cancer J. 2004 May-Jun;10(3):170-4.

Wirth MP, Weissbach L, Marx FJ, Heckl W, Jellinghaus W, Riedmiller H, Noack B, Hinke A, Froehner M.
Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancer. Eur Urol. 2004 Mar;45(3):267-70; discussion 270.

Freedland SJ, Presti JC Jr, Kane CJ, Aronson WJ, Terris MK, Dorey F, Amling CL; SEARCH Database Study Group.
Do younger men have better biochemical outcomes after radical prostatectomy? Urology. 2004 Mar;63(3):518-22.

Fountzilas G, Ciuleanu E, Dafni U, Plataniotis G, Kalogera-Fountzila A, Samantas E, Athanassiou E, Tzitzikas J, Ciuleanu T, Nikolaou A, Pantelakos P, Zaraboukas T, Zamboglou N, Daniilidis J, Ghilezan N.
Concomitant Radiochemotherapy vs Radiotherapy Alone in Patients with Head and Neck Cancer: A Hellenic Cooperative Oncology Group Phase III Study. Med Oncol. 2004;21(2):95-108.